Sanofi

reshuffle pipeline target reorganize shift change
Biotech

Recursion streamlines pipeline following merger with Exscientia

Evidently in the mood for spring cleaning, Recursion is clearing out part of its pipeline as it narrows its focus on oncology and rare diseases.
Fraiser Kansteiner May 5, 2025 11:00am
MA strategy deal block push come together form

M&A remains ‘top priority’ for pharmas in face of tariff threat

Apr 25, 2025 10:41am
abstract black agate background with golden veins fake painted artificial stone marble texture

Versant unveils new autoimmune biotech with $100M fundraise

Apr 24, 2025 8:00am
pivot change turnaround direction walk away

Sanofi's oral TNF asset misses mark in phase 2 psoriasis trial

Apr 24, 2025 4:46am
Sanofi

Sanofi hands cancer drug to Innate as it pivots R&D pact focus

Apr 23, 2025 6:35am
Sanofi

Sanofi pens $1.8B deal for 2 autoimmune, immunology bispecifics

Apr 17, 2025 8:51am